Ostrum Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$348K Buy
5,538
+81
+1% +$5.64K 0.02% 386
2025
Q4
$362K Sell
5,457
-1,809
-25% -$117K 0.02% 409
2025
Q3
$489K Buy
7,266
+5,366
+282% +$425K 0.02% 409
2025
Q2
$166K Sell
1,900
-2,535
-57% -$199K 0.01% 504
2025
Q1
$303K Sell
4,435
-1,876
-30% -$153K 0.02% 456
2024
Q4
$491K Buy
6,311
+2,642
+72% +$196K 0.04% 405
2024
Q3
$246K Sell
3,669
-1,276
-26% -$105K 0.02% 471
2024
Q2
$561K Sell
4,945
-4,346
-47% -$549K 0.05% 382
2024
Q1
$1.29M Buy
9,291
+600
+7% +$75.4K 0.1% 301
2023
Q4
$1.08M Buy
8,691
+1,786
+26% +$182K 0.09% 303
2023
Q3
$644K Buy
6,905
+2,223
+47% +$251K 0.06% 400
2023
Q2
$602K Buy
4,682
+3
+0.1% +$363 0.05% 406
2023
Q1
$544K Buy
+4,679
New +$524K 0.05% 413

Other funds holding DXCM

Ostrum Asset Management's DXCM Position: Q1 2026 in Review

Ostrum Asset Management increased its DexCom (DXCM) stake by 1.5% in Q1 2026, buying an estimated $5.64K and bringing the position to 5,538 shares worth $348K. The position accounts for 0.02% of the portfolio, ranked #386.

Ostrum Asset Management first reported a position in DXCM in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.29M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Ostrum Asset Management held 5,538 shares of DexCom worth $348K as of Q1 2026.
  • Ostrum Asset Management bought 81 DexCom shares in Q1 2026, an estimated $5.64K.
  • DexCom made up 0.02% of Ostrum Asset Management's portfolio in Q1 2026, its #386 holding.
  • Ostrum Asset Management first reported a position in DexCom in Q1 2023 and has held it in 13 quarters since.
  • Ostrum Asset Management's DexCom position peaked at $1.29M in Q1 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Ostrum Asset Management's 13F filing for Q1 2026, filed 14 May 2026.